Molecular Templates Revenue
Biotechnology Research • 
Austin, Texas, United States • 21-50 Employees
Molecular Templates revenue & valuation
| Annual revenue | $25,500,000 |
| Revenue per employee | $849,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $81,600,000 |
| Total funding | $85,400,000 |
Key Contacts at Molecular Templates
John Haney
Sr Director, Biopharmaceutical Project Management
Jesse Xu
Financial Director
Company overview
| Headquarters | 9301 Amberglen Blvd, Suite 100, Austin, Texas 78729, US |
| Phone number | +15128961555 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Biotechnology, Antibodies, Biologics, ETB, Immunooncology, Onoclogy |
| Founded | 2001 |
| Employees | 21-50 |
| Socials |
Molecular Templates Email Formats
Molecular Templates uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@mtem.com), used 68.4% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@mtem.com | 68.4% |
{first name}.{last name} | john.doe@mtem.com | 31.6% |
About Molecular Templates
Molecular Templates, Inc. (MTEM) is a clinical stage biopharmaceutical company focused on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform with unique mechanisms of actions which are highly differentiated from antibody drug conjugates (ADCs). MTEM is developing MT-6402, which is in a Phase I clinical trial for PD-1/PD-L1 antibody relapsed/refractory patients; MT-5111, which is in a Phase I clinical trial for the treatment of HER2-positive cancers; and MT-0169, which is in a Phase I clinical trial to treat relapsed/refractory myeloma. MTEM’s pipeline of ETBs in development for other targets include CTLA-4, TIGIT, TROP2, and BCMA. MTEM has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Molecular Templates has 10 employees across 7 departments.
Departments
Number of employees
Funding Data
Explore Molecular Templates's funding history, including investment rounds, total capital raised, and key backers.
Molecular Templates Tech Stack
Discover the technologies and tools that power Molecular Templates's digital infrastructure, from frameworks to analytics platforms.
Web servers
Security
JavaScript libraries
Analytics
JavaScript libraries
JavaScript libraries
Miscellaneous
UI frameworks
Miscellaneous
Miscellaneous
Font scripts
Canada
Italy
United Kingdom
Frequently asked questions
4.8
40,000 users
